
Aignostics is an AI-powered company transforming drug development and improving patient outcomes through precision medicine. They offer a range of products including Foundation Models and the Atlas H&E-TME profiling application, supported by custom services for target and biomarker discovery, translational research, and digital diagnostics. The company emphasizes its deep biomedical expertise, advanced machine learning capabilities, and collaborations with academic institutions. Aignostics, a spin-off from Charité Berlin, has offices in Berlin and New York, and is certified with ISO 13485 and 27001, with a GCP-ready clinical trial platform. They have raised $55 million in funding and employ over 120 people.

Aignostics is an AI-powered company transforming drug development and improving patient outcomes through precision medicine. They offer a range of products including Foundation Models and the Atlas H&E-TME profiling application, supported by custom services for target and biomarker discovery, translational research, and digital diagnostics. The company emphasizes its deep biomedical expertise, advanced machine learning capabilities, and collaborations with academic institutions. Aignostics, a spin-off from Charité Berlin, has offices in Berlin and New York, and is certified with ISO 13485 and 27001, with a GCP-ready clinical trial platform. They have raised $55 million in funding and employ over 120 people.
Headquarters: Berlin and New York
Founded: 2018 (spun out 2020)
Sector: AI-powered computational pathology / biotechnology
Recent raise: $34M Series B (Oct 29, 2024)
Total disclosed funding: ≈ $55M
Employees: ≈ 137
Translating complex biomedical imaging data into actionable insights for precision medicine and drug development.
2018
Biotechnology
€5,000,000
€14,000,000
$34,000,000
Participants included Mayo Clinic, HTGF and existing investors
“Includes strategic and healthcare-focused investors such as ATHOS, Mayo Clinic, Wellington Partners, Boehringer Ingelheim Venture Fund, HTGF and IBB Ventures”
| Company |
|---|
Why us?
We believe that AI has the potential to revolutionize how cancer and other complex diseases are diagnosed and treated. We also believe that AI is a tool, not an identity – without access to high quality data and a scientifically rigorous, transparent approach to model development, AI is just a buzzword. That’s where we come in.
Aignostics is a spin-off from one of Europe's largest and most prestigious university hospitals (Charité), with employees in Berlin and New York. We have received over $50M in funding from leading investors and are a growing team of over 100 interdisciplinary professionals. We work with academic partners as well as leading global life sciences companies.
As a Senior Machine Learning Engineer at Aignostics, you work hand in hand with our collaborators in academia and industry to push the state of the art of machine learning for digital pathology. You will develop distributed software systems for machine learning applications that will help to improve cancer research and diagnostics. Together with your colleagues you will take care of the machine learning software stack and thereby enable our teams to build medical grade quality and scalable machine learning models.
At Aignostics, we believe that fighting cancer is a job for people of all identities, backgrounds, and cultures. We value and celebrate diversity and inclusion and are committed to offering equal employment and promotion opportunities for all applicants and employees. Applicants will be considered regardless of their age, disability, ethnicity, race, gender identity or expression, sexual orientation, religion, etc. We thrive through collaboration and believe the more inclusive we are, the better our work will be.
Please note that this position is intended for software engineers. For a data scientist / machine learning / deep learning position please check out our Data Scientist opening. Where your expertise is needed
What we are looking for
Nice to have
We are still keen to hear from you if you don't match all the above points! Our needs are diverse and growing and you are encouraged to apply if you have any combination of these skills. The recruitment process is a comparative exercise and decisions will be made based on the applications we review at each time.
Our offer
Join us to make a difference!
We are an international, interdisciplinary team that is powering the next generation of precision medicine and advancing the fields of AI and pathology.